Recently Funded Biotech Companies 2026
Biotechnology and genomics companies whose latest recorded funding round was announced in the last 90 days.
Known total funding for 53 of 56 ranked companies: $8.1B.
Showing top 56 matching companies · Ranked by most recent funding
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&fundedAfter=2026-08-11&operatingStatus=active&sort=last_funding_date&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"The API has no company type filter, so public companies can appear; this list counts private companies only.
The API cannot leave out companies whose latest round is a grant; this list does.
Methodology: up to 100 active companies matching this list's filters are ordered by most recent announced round. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.
What changed in the last 90 days
Indexed tracks 55 Biotech funding rounds with known USD amounts announced since Aug 11, 2026, totaling $4.3B. The largest were Enveda ($311.0M, Series E), OMass Therapeutics ($310.0M, Series C) and Encoded Therapeutics ($275.0M, Series F). As of Nov 9, 2026.
